FACTORS ASSOCIATED WITH BIOLOGIC TREATMENT DE-ESCALATION IN PATIENTS WITH CROHN'S DISEASE

被引：0
|
作者：
Lien, P. W. [1 ]
Lee, T. A. [2 ]
机构：
[1] Univ Illinois, Chicago, IL USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO117
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [21] EFFECTIVENESS OF DOSE DE-ESCALATION OF BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW
    Little, Derek H.
    Tabatabavakili, Sahar
    Shaffer, Seth
    Weizman, Adam V.
    Nguyen, Geoffrey C.
    Targownik, Laura E.
    GASTROENTEROLOGY, 2020, 158 (06) : S670 - S671
  • [22] FACTORS DRIVING TREATMENT ESCALATION IN CROHN'S DISEASE IN THE CALM TRIAL
    Reinisch, Walter
    Panaccione, Remo
    Bossuyt, Peter
    Baert, Filip J.
    Armuzzi, Alessandro
    Hebuterne, Xavier
    Danese, Silvio
    Sandborn, William J.
    Schreiber, Stefan
    D'Haens, Geert R.
    Berg, Sofie
    Zhou, Qian
    Petersson, Joel H.
    Neimark, Ezequiel
    Robinson, Anne M.
    Colombel, Jean Frederic
    GASTROENTEROLOGY, 2018, 154 (06) : S81 - S81
  • [23] Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review
    Little, Derek H. W.
    Tabatabavakili, Sahar
    Shaffer, Seth R.
    Nguyen, Geoffrey C.
    Weizman, Adam, V
    Targownik, Laura E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11) : 1768 - 1774
  • [24] De-Escalation of Therapy Is Not Cost-Effective in Patients With Crohn's Disease in Clinical Remission on Combination Therapy With Infliximab and Azathioprine
    Syal, Gaurav
    Almario, Christopher
    Melmed, Gil Y.
    Spiegel, Brennan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S349 - S349
  • [25] PATIENT ATTITUDES REGARDING CONTINUATION AND DE-ESCALATION OF BIOLOGIC THERAPY
    Kim, Emilie Soyeon
    Kumar, Anand
    Kozan, Philip
    Meira, Abramowitz
    Jacob, Vinita
    Scherl, Ellen J.
    Longman, Randy S.
    Battat, Robert
    Lukin, Dana J.
    GASTROENTEROLOGY, 2020, 158 (06) : S436 - S437
  • [26] Antibiotic de-escalation in the treatment of sepsis
    Shime, Nobuaki
    Hashimoto, Satoru
    Fujita, Naohisa
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A252 - A252
  • [27] De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
    Karim Jaffal
    Julien Poissy
    Anahita Rouze
    Sébastien Preau
    Boualem Sendid
    Marjorie Cornu
    Saad Nseir
    Annals of Intensive Care, 8
  • [28] De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety
    Jaffal, Karim
    Poissy, Julien
    Rouze, Anahita
    Preau, Sebastien
    Sendid, Boualem
    Cornu, Marjorie
    Nseir, Saad
    ANNALS OF INTENSIVE CARE, 2018, 8
  • [29] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [30] REAL-LIFE DOSE ESCALATION OF PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE UNDERGOING BIOLOGIC TREATMENT IN PORTUGAL
    Lopes da Cruz, J. P.
    Faria, M.
    Aleixo, A. S.
    Pereira, F.
    VALUE IN HEALTH, 2023, 26 (12) : S533 - S533
12345